Literature DB >> 8719684

Histopathologic observations on human eyes following neodymium: YAG laser cyclophotocoagulation for glaucoma.

A P Ferry1, M H King, D W Richards.   

Abstract

PURPOSE: Although Nd:YAG laser cyclophotocoagulation has been extensively used for nearly a decade in treatment of severe glaucoma, there have been remarkably few reports (each of them extremely brief) of histopathological examination of glancomatous human eyes that had been so treated. We undertook this study to provide further details regarding the nature of the lesions produced in this type of ciliary ablation.
METHODS: We chose three representative cases in which a glaucomatous human eye had been subjected to Nd: YAG cyclophotocoagulation, and was subsequently enucleated. To better understand the temporal evolution of the lesions, we selected eyes that were enucleated 1 day, 20 days, and 3 months, respectively, after they had been treated with noncontact Nd: YAG laser cyclophotocoagulation. RESULTS AND
CONCLUSIONS: (1) energy levels ranging from 4.4 Joules to 5.6 Joules were effective in producing appropriate lesions; (2) direction of the laser beam 1 to 1.5 mm behind the limbus caused severe destructive lesions of the pars plicata: (3) toward the periphery of the individual treatment sites, the stroma and ciliary muscle continued to exhibit severe degeneration, as did the epithelium lining the valleys between the crests of the ciliary processes; but in those peripheral zones of individual treatment sites, the epithelium lining the crests of the ciliary processes survived and appears normal; (4) bleb-like separations of the ciliary epithelium from the adjacent stroma, particularly along the posterior aspect of the ciliary body lesions, are a prominent early feature of Nd:YAG cyclophotocoagulation; (5) the pigmented epithelium is more vulnerable to laser energy than is the nonpigmented epithelium of the ciliary body; (6) the destruction of the ciliary epithelium is permanent; (7) deeply pigmented persons have more melanocytes in the ciliary body muscle and stroma than do more lightly pigmented individuals, a circumstance that renders the tissues more vulnerable to laser energy; (8) the ciliary muscle was always severely damaged; (9) no scleral injury was observed other than evanescent, focal areas of edema of the deep sclera; and (10) except in the episclera, inflammatory cells were strikingly few in number, a circumstance providing support for the clinical observation that eyes treated with laser cyclophotocoagulation exhibit less of an inflammatory response than do those treated with cyclocryotherapy.

Entities:  

Mesh:

Year:  1995        PMID: 8719684      PMCID: PMC1312063     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  25 in total

1.  Histopathologic observations on human eyes following cyclocryotherapy for glaucoma.

Authors:  A P Ferry
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 Jan-Feb

2.  Histologic effects of cyclophotocoagulation.

Authors:  W F March; R P Shaver
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

3.  Transscleral neodymium-YAG cyclophotocoagulation. A histologic study of human autopsy eyes.

Authors:  C Hampton; M B Shields
Journal:  Arch Ophthalmol       Date:  1988-08

4.  Histopathologic findings after Nd:YAG transscleral cyclophotocoagulation.

Authors:  S M Shields; J L Stevens; M A Kass; M E Smith
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

5.  Staphloma following cyclocryotherapy.

Authors:  R H Stewart; C A Garcia
Journal:  Ophthalmic Surg       Date:  1974

6.  Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma.

Authors:  H Beckman; A Kinoshita; A N Rota; H S Sugar
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 Mar-Apr

7.  [Changes in the outflow facility following cyclocryocoagulation in primary glaucoma. A tonographic study].

Authors:  T P Duy; T Seiler; J Wollensak
Journal:  Klin Monbl Augenheilkd       Date:  1987-02       Impact factor: 0.700

8.  Transscleral cyclophotocoagulation using a neodymium YAG laser.

Authors:  F Fankhauser; E van der Zypen; S Kwasniewska; P Rol; C England
Journal:  Ophthalmic Surg       Date:  1986-02

9.  Neodymium: YAG transscleral cyclocoagulation in human eyes.

Authors:  R G Devenyi; G E Trope; W H Hunter; O Badeeb
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

10.  The role of inflammation in CW Nd:YAG contact transscleral photocoagulation and cryopexy.

Authors:  H D Schubert; J L Federman
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-03       Impact factor: 4.799

View more
  5 in total

1.  Endoscopic and transscleral cyclophotocoagulation.

Authors:  P A Bloom; S Dharmaraj
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

2.  Pathology of cyclodiode laser: a series of nine enucleated eyes.

Authors:  P A McKelvie; M J Walland
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Transscleral cyclophotocoagulation in refractory acute and chronic angle closure glaucoma.

Authors:  Imran H Yusuf; Mital Shah; Asifa Shaikh; C Bruce James
Journal:  BMJ Case Rep       Date:  2015-09-30

4.  Transvitreal endocyclophotocoagulation.

Authors:  J A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 5.  Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options.

Authors:  Anna I Dastiridou; Andreas Katsanos; Philippe Denis; Brian A Francis; Dimitrios G Mikropoulos; Miguel A Teus; Anastasios-Georgios Konstas
Journal:  Adv Ther       Date:  2018-11-17       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.